Literature DB >> 8211663

Primary malignant rhabdoid tumor of the central nervous system: case report and review of the literature.

H Satoh1, J Goishi, T Sogabe, T Uozumi, K Kiya, K Migita.   

Abstract

Malignant rhabdoid tumor (MRT) is well known as a pediatric malignant tumor of the kidney. Only nine cases of primary MRT of the central nervous system (CNS) have been reported. We are reporting in detail the clinical course and treatment of a patient with primary MRT of the CNS. We cared for a 3-year-old girl with an MRT that extended from the internal auditory canal to the cerebellopontine angle. Despite three surgical attempts at resecting the tumor combined with whole craniospinal axis irradiation, as well as chemotherapy consisting of intravenous nimustine hydrochloride and intrathecal methotrexate injections, the patient died 13 months after her initial hospitalization. The origin of CNS-MRT development is still a question of pathologic debate. Like renal MRT, the prognosis of MRT of the CNS is very poor. The dissemination of MRT of the CNS occurred in most cases.

Entities:  

Mesh:

Year:  1993        PMID: 8211663     DOI: 10.1016/0090-3019(93)90226-q

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  9 in total

1.  Malignant rhabdoid tumor of the small intestine in an adult: a case report with immunohistochemical and ultrastructural findings.

Authors:  Y Chen; S M Jung; T C Chao
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

2.  Primary malignant rhabdoid tumors of the central nervous system: considerations about two cases of adulthood presentation.

Authors:  José Pimentel; Rita Silva; Teresa Pimentel
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

Review 3.  Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.

Authors:  Mary Ann Zimmerman; Liliana C Goumnerova; Mark Proctor; R Michael Scott; Karen Marcus; Scott L Pomeroy; Christopher D Turner; Susan N Chi; Christine Chordas; Mark W Kieran
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

Review 4.  Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy.

Authors:  Sarah E Squire; Michael D Chan; Karen J Marcus
Journal:  J Neurooncol       Date:  2006-07-20       Impact factor: 4.130

5.  Primary malignant rhabdoid tumor of the central nervous system--a comprehensive review.

Authors:  Ismail H Tekkök; Aydin Sav
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

Review 6.  Central nervous system atypical teratoid tumor/rhabdoid tumor: response to intensive therapy and review of the literature.

Authors:  J M Hilden; J Watterson; D C Longee; C L Moertel; M E Dunn; J Kurtzberg; B W Scheithauer
Journal:  J Neurooncol       Date:  1998-12       Impact factor: 4.130

7.  Central nervous system atypical teratoid rhabdoid tumor: experience at the National Institute of Pediatrics, Mexico City.

Authors:  Beatriz de León-Bojorge; Fernando Rueda-Franco; Marcial Anaya-Jara
Journal:  Childs Nerv Syst       Date:  2007-09-18       Impact factor: 1.475

Review 8.  Atypical teratoid rhabdoid tumor of the brain: case series and review of literature.

Authors:  Ahitagni Biswas; Shikha Goyal; Tarun Puri; Prasenjit Das; Chitra Sarkar; Pramod Kumar Julka; Sameer Bakhshi; Goura Kishor Rath
Journal:  Childs Nerv Syst       Date:  2009-05-30       Impact factor: 1.475

9.  Atypical teratoid rhabdoid tumor: current therapy and future directions.

Authors:  Kevin F Ginn; Amar Gajjar
Journal:  Front Oncol       Date:  2012-09-12       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.